The Center for Disease Control and Prevention (CDC) has resumed cerebral palsy (CP) tracking and monitoring at sites in the following five states: Minnesota, Missouri, Utah, Tennessee and Georgia.
Surveillance of cerebral palsy children were re-established across the Autism and Developmental Disabilities Monitoring (ADDM) Network in 2023. The reporting of preliminary findings of CP surveillance and the development of recommendations for inclusion of CP in surveillance year 2024 activities is currently ongoing.
Additional information
Generally stated the incidence of Cerebral Palsy is 2-3/1000 live births (Vitrikas et al, 2020).
It is the most common neuromotor disability of children.
Approximately 92% of cases of cerebral palsy are traced to the perinatal period (Morgan et al. 2018).
Risk factors include preterm birth, perinatal infection (particularly chorioamnionitis), intrauterine growth restriction, use of preterm antibiotics before rupture of membranes, acidosis or asphyxia, and multiple gestation (Bjorga & Hysing, 2012).
Fewer than 10% of cases are attributable to intrapartum hypoxia with about 8% of patients occurring at an older age due to head injuries or infections (Morgan, 2018).
References
Bjorgaas, H.M., Hysing, M. &, Elgen, I. (2012). Psychiatric disorders among children with cerebral palsy at school starting age. Res Dev Disabil. 33(4),1287-1293.
CDC. (2023). What is cerebral palsy? https://www.cdc.gov/ncbddd/cp/facts.html.
Morgan. C., Fahey, M., Roy, B., et al. (2018). Diagnosing cerebral palsy in full-term infants. J Paediatr Child Health. 54(10),1159-1164.